|
Listen to this article  |
New CMR Surgical non-executive chair Daniel Moore. | Source: Daniel Moore on LinkedIn
CMR Surgical this week appointed Daniel Moore as non-executive chair of its board of directors, effective immediately. Moore brings more than 35 years of experience in the medtech industry, including nearly 20 years spent at Boston Scientific. There, he took up multiple senior executive roles, including president of inter-continental and distribution management.
Most recently, Moore served as chair of the board at LivaNova. Before the merger of Sorin and Cyberonics that formed LivaNova, he was president and CEO of Cyberonics for eight years. Additionally, Moore brings significant board-level executive experience in medtech. He served as chair at Brainscope, GI Dynamics, and the Medical Device Manufacturers Association (MDMA).
As chair of CMR Surgical, the company expects Moore to continue driving its growth strategy and bring its Versius surgical robot to more hospitals around the world. CEO Supratim Bose said in a news release that Moore brings “invaluable” sector experience and leadership.
“The surgical robotics sector is one of the most exciting in the medtech space, and Versius is a truly differentiated technology with many large untapped markets yet to be reached, and more patients to be served,” Moore said. “I look forward to working with the Board, Supratim and the leadership team to help realize the vision of the company and true promise of Versius.”
Versius, a small-scale surgical robotic system, features collaborative arms and bedside units for direct patient access. It also features offers of port placement to best suit the needs of each patient. CMR Surgical designed Versius to enable surgeons to perform more minimal access surgery. Its minimally invasive approach assists surgeons in accessing the lungs, thymus, and esophagus.
CMR enhances surgical robot with new imaging tech
CMR Surgical’s Versius surgical robotics system in action. | Source: CMR Surgical
Earlier this year, CMR launched vLimeLite, an integrated fluorescence imaging system that works with its Versius Plus surgical robot. The company said the imaging system is intended to help surgeons perform visual assessment of blood flow, vessels, and related tissue perfusion, as well as biliary anatomy.
vLimeLight enables visualization of ICG (Indocyanine green) and offers options for viewing mode, asserted the company. Surgeons can choose to overlay in greyscale or overlay in full color, and they can choose green or cyan for ICG color.
Versius Plus is the first CE-marked surgical robot to offer this type of integrated ICG system, claimed CMR Surgical. The company also said it marks the first in a series of product releases planned for 2024.
Editor’s Note: This article was syndicated from The Robot Report’s sibling site MassDevice.